Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).
Certolizumab Pegol
C87032
NCT00152425
Crohn's Disease
Phase 3
 
Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only
July 2014

Powered by ideaPoint, Inc.